By assessing how “sticky” tumor cells are, researchers at the University of California San Diego have found a potential way to predict whether a patient’s early-stage breast cancer is likely to spread. The discovery, made possible by a specially designed microfluidic device, could help doctors identify high-risk patients and tailor their treatments accordingly.
 
            
                    
Leave A Comment